Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Avidity Biosciences (RNA) Return on Assets (2020 - 2025)

Historic Return on Assets for Avidity Biosciences (RNA) over the last 6 years, with Q3 2025 value amounting to 0.31%.

  • Avidity Biosciences' Return on Assets fell 1300.0% to 0.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.31%, marking a year-over-year decrease of 1300.0%. This contributed to the annual value of 0.29% for FY2024, which is 400.0% up from last year.
  • According to the latest figures from Q3 2025, Avidity Biosciences' Return on Assets is 0.31%, which was down 1300.0% from 0.32% recorded in Q2 2025.
  • Avidity Biosciences' 5-year Return on Assets high stood at 0.19% for Q3 2024, and its period low was 0.38% during Q3 2022.
  • For the 5-year period, Avidity Biosciences' Return on Assets averaged around 0.29%, with its median value being 0.3% (2022).
  • As far as peak fluctuations go, Avidity Biosciences' Return on Assets tumbled by -1600bps in 2021, and later soared by 1500bps in 2024.
  • Avidity Biosciences' Return on Assets (Quarter) stood at 0.28% in 2021, then fell by -18bps to 0.33% in 2022, then fell by -8bps to 0.35% in 2023, then skyrocketed by 43bps to 0.2% in 2024, then plummeted by -56bps to 0.31% in 2025.
  • Its Return on Assets was 0.31% in Q3 2025, compared to 0.32% in Q2 2025 and 0.24% in Q1 2025.